This company listing is no longer active
Salud financiera de hoja de balance de Vilmorin & Cie
Salud financiera controles de criterios 3/6
Vilmorin & Cie has a total shareholder equity of €1.4B and total debt of €1.5B, which brings its debt-to-equity ratio to 107.9%. Its total assets and total liabilities are €3.8B and €2.4B respectively. Vilmorin & Cie's EBIT is €151.2M making its interest coverage ratio 4.8. It has cash and short-term investments of €296.0M.
Información clave
107.9%
Ratio deuda-patrimonio
€1.51b
Deuda
| Ratio de cobertura de intereses | 4.8x |
| Efectivo | €296.00m |
| Patrimonio | €1.40b |
| Total pasivo | €2.38b |
| Activos totales | €3.78b |
Actualizaciones recientes sobre salud financiera
Does Vilmorin & Cie (EPA:RIN) Have A Healthy Balance Sheet?
Mar 03
Vilmorin & Cie (EPA:RIN) Takes On Some Risk With Its Use Of Debt
Mar 16Recent updates
Vilmorin & Cie (EPA:RIN) Has More To Do To Multiply In Value Going Forward
Feb 07Vilmorin & Cie (EPA:RIN) Has More To Do To Multiply In Value Going Forward
Aug 03Is There An Opportunity With Vilmorin & Cie SA's (EPA:RIN) 44% Undervaluation?
Jul 06Is Now An Opportune Moment To Examine Vilmorin & Cie SA (EPA:RIN)?
Jun 14Does Vilmorin & Cie (EPA:RIN) Have A Healthy Balance Sheet?
Mar 03Returns On Capital At Vilmorin & Cie (EPA:RIN) Have Stalled
Feb 10Vilmorin & Cie (EPA:RIN) Is Paying Out A Larger Dividend Than Last Year
Dec 12Is Now The Time To Look At Buying Vilmorin & Cie SA (EPA:RIN)?
Nov 07Vilmorin & Cie (EPA:RIN) Is Increasing Its Dividend To €1.60
Oct 16There's Been No Shortage Of Growth Recently For Vilmorin & Cie's (EPA:RIN) Returns On Capital
Oct 05Is There An Opportunity With Vilmorin & Cie SA's (EPA:RIN) 42% Undervaluation?
Jul 06Vilmorin & Cie (EPA:RIN) Is Doing The Right Things To Multiply Its Share Price
Jun 10At €57.50, Is It Time To Put Vilmorin & Cie SA (EPA:RIN) On Your Watch List?
May 26Calculating The Intrinsic Value Of Vilmorin & Cie SA (EPA:RIN)
Mar 29Vilmorin & Cie (EPA:RIN) Takes On Some Risk With Its Use Of Debt
Mar 16What Do The Returns On Capital At Vilmorin & Cie (EPA:RIN) Tell Us?
Mar 03Here's How We Evaluate Vilmorin & Cie SA's (EPA:RIN) Dividend
Feb 16
Vilmorin & Cie SA's (EPA:RIN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 01At €50.20, Is It Time To Put Vilmorin & Cie SA (EPA:RIN) On Your Watch List?
Jan 19Vilmorin & Cie's (EPA:RIN) Shareholders Are Down 39% On Their Shares
Jan 05Calculating The Intrinsic Value Of Vilmorin & Cie SA (EPA:RIN)
Dec 23Should Income Investors Look At Vilmorin & Cie SA (EPA:RIN) Before Its Ex-Dividend?
Dec 09How Does Vilmorin & Cie's (EPA:RIN) CEO Pay Compare With Company Performance?
Nov 30How Does Vilmorin & Cie SA (EPA:RIN) Fare As A Dividend Stock?
Nov 17Análisis de la situación financiera
Pasivos a corto plazo: RIN's short term assets (€1.7B) exceed its short term liabilities (€997.2M).
Pasivo a largo plazo: RIN's short term assets (€1.7B) exceed its long term liabilities (€1.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: RIN's net debt to equity ratio (86.8%) is considered high.
Reducción de la deuda: RIN's debt to equity ratio has increased from 101.6% to 107.9% over the past 5 years.
Cobertura de la deuda: RIN's debt is not well covered by operating cash flow (18.1%).
Cobertura de intereses: RIN's interest payments on its debt are well covered by EBIT (4.8x coverage).